Income Statement | | | | | | | | | | | | |
| | | | | | | | | | | | Original |
USD | Fiscal Year Ending | | Latest |
(in millions) | Dec-15 | Dec-16 | Dec-17 | Dec-18 | Dec-19 | Dec-20 | Dec-21 | Dec-22 | Dec-23 | Dec-24 | | Dec-24 |
| FY - 9 | FY - 8 | FY - 7 | FY - 6 | FY - 5 | FY - 4 | FY - 3 | FY - 2 | FY - 1 | FY | | LTM |
| | | | | | | | | | | | |
Revenue | 28 | 43 | 50 | 61 | 56 | 49 | 64 | 76 | 56 | 61 | | 61 |
% Growth | NA | 56.3% | 14.0% | 22.4% | -8.1% | -13.0% | 32.5% | 18.1% | -26.2% | 8.1% | | |
| | | | | | | | | | | | |
Cost of Revenue | (16) | (24) | (26) | (34) | (30) | (26) | (40) | (48) | (35) | (36) | | (36) |
Gross Profit | 12 | 19 | 23 | 27 | 25 | 23 | 25 | 28 | 21 | 25 | | 25 |
% Revenue | 41.9% | 44.4% | 47.1% | 43.7% | 45.4% | 46.6% | 38.3% | 36.9% | 37.1% | 40.9% | | 40.9% |
| | | | | | | | | | | | |
Research and Development | (4) | (6) | (7) | (9) | (9) | (9) | (11) | (11) | (11) | (12) | | (12) |
Selling and Marketing | (4) | (6) | (7) | (10) | (7) | (6) | (10) | (11) | (9) | (9) | | (9) |
General and Admin | (3) | (5) | (8) | (9) | (9) | (10) | (14) | (14) | (14) | (13) | | (13) |
Other Inc / (Exp) | (0) | 0 | 0 | (2) | 0 | (0) | (2) | (0) | (0) | (0) | | (0) |
Total Operating Exp | (12) | (15) | (22) | (30) | (25) | (26) | (37) | (37) | (33) | (34) | | (34) |
| | | | | | | | | | | | |
Operating Income | (0) | 4 | 1 | (3) | 0 | (3) | (12) | (9) | (12) | (9) | | (9) |
% Revenue | -0.8% | 9.0% | 2.0% | -5.0% | 0.7% | -6.6% | -18.9% | -11.4% | -22.1% | -14.8% | | -14.8% |
| | | | | | | | | | | | |
Interest Expense | (2) | (2) | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | | 0 |
Pre-tax Income | (3) | 2 | 1 | (2) | 1 | (3) | (12) | (9) | (12) | (9) | | (9) |
Earnings of Discontinued Ops. | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Provision for Taxes | (0) | (0) | (0) | (0) | (0) | (0) | 2 | (0) | (0) | 0 | | 0 |
Net Income to Company | (3) | 2 | 1 | (3) | 1 | (3) | (10) | (9) | (12) | (9) | | (9) |
% Margin | -9.8% | 5.1% | 2.3% | -4.3% | 1.7% | -6.8% | -15.7% | -11.4% | -22.2% | -14.3% | | -14.3% |
| | | | | | | | | | | | |
Minority Interest in Earnings | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Net Income to Stockholders | (3) | 2 | 1 | (3) | 1 | (3) | (10) | (9) | (12) | (9) | | (9) |
| | | | | | | | | | | | |
Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Other Adj. | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
| | | | | | | | | | | | |
Net Income to Common | (3) | 2 | 1 | (3) | 1 | (3) | (10) | (9) | (12) | (9) | | (9) |
% Margin | -9.8% | 5.1% | 2.3% | -4.3% | 1.7% | -6.8% | -15.7% | -11.4% | -22.2% | -14.3% | | -14.3% |
| | | | | | | | | | | | |
As Reported | | | | | | | | | | | | |
Basic EPS (Continuing Ops) | (4.17) | 0.65 | 0.12 | (0.27) | 0.10 | (0.34) | (1.01) | (0.85) | (1.20) | (0.79) | | (0.79) |
Diluted EPS (Continuing Ops) | (4.30) | 0.40 | 0.11 | (0.27) | 0.09 | (0.34) | (1.01) | (0.85) | (1.20) | (0.79) | | (0.79) |
| | | | | | | | | | | | |
WA Basic Shares Out. | 0.65 | 3.37 | 9.49 | 9.52 | 9.68 | 9.71 | 10.02 | 10.19 | 10.39 | 11.05 | | 11.05 |
WA Diluted Shares Out. | 0.65 | 4.67 | 10.36 | 9.52 | 10.10 | 9.71 | 10.02 | 10.19 | 10.39 | 11.05 | | 11.05 |
| | | | | | | | | | | | |
EBITDA, EBIT Reconciliation | | | | | | | | | | | | |
EBT, Incl. Unusual Items | (3) | 2 | 1 | (2) | 1 | (3) | (12) | (9) | (12) | (9) | | (9) |
Addback: Net Interest Expense | 2 | 2 | (0) | (1) | (1) | (0) | (0) | (0) | (0) | (0) | | (0) |
Addback: Other Non Operating Expenses, Total | 0 | (0) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Depreciation & Amortization | 0 | 1 | 1 | 1 | 1 | 1 | 4 | 4 | 4 | 4 | | 4 |
Addback: Restructuring Charges | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Merger / Acquisition Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Goodwill Impairment | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Gain (Loss) On Sale Of Invest. | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Gain (Loss) On Sale Of Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Asset Writedown | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: In Process R&D Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Insurance Settlements | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Legal Settlements | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Other Unusual Items | 0 | 0 | 0 | 2 | 0 | 0 | 2 | 0 | 0 | 0 | | 0 |
Adjusted EBITDA | 0 | 4 | 2 | (0) | 2 | (2) | (7) | (5) | (9) | (5) | | (5) |
% Margin | 1.3% | 9.9% | 4.0% | -0.2% | 2.7% | -4.3% | -10.2% | -6.4% | -15.6% | -8.8% | | -8.8% |
| | | | | | | | | | | | |
Adjusted EBIT | (0) | 3 | 1 | (1) | 0 | (3) | (10) | (9) | (12) | (9) | | (9) |
% Margin | -0.4% | 7.9% | 2.0% | -2.3% | 0.7% | -6.6% | -15.7% | -11.3% | -22.1% | -14.7% | | -14.7% |
| | | | | | | | | | | | |
Adjusted Net Income Reconciliation | | | | | | | | | | | | |
Net Income to Company | (3) | 2 | 1 | (3) | 1 | (3) | (10) | (9) | (12) | (9) | | (9) |
Addback: Unusual Items | 0 | 0 | 0 | 2 | 0 | 0 | 2 | 0 | 0 | 0 | | 0 |
Less: Tax Benefit of Unusual Items (26%) | 0 | 0 | 0 | (0) | 0 | (0) | (1) | (0) | 0 | 0 | | 0 |
Adjusted Net Income | (3) | 2 | 1 | (1) | 1 | (3) | (9) | (9) | (12) | (9) | | (9) |
% Margin | -9.8% | 5.1% | 2.3% | -2.2% | 1.7% | -6.7% | -13.3% | -11.4% | -22.2% | -14.3% | | -14.3% |